Exome Asset Management as of March 31, 2025
Portfolio Holdings for Exome Asset Management
Exome Asset Management holds 59 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 5.1 | $5.7M | 166k | 34.57 | |
| Guardant Health (GH) | 4.8 | $5.4M | 127k | 42.60 | |
| Geron Corporation (GERN) | 4.5 | $5.1M | 3.2M | 1.59 | |
| Astrazeneca Sponsored Adr | 4.2 | $4.7M | 33k | 145.26 | |
| Cytokinetics Com New (CYTK) | 3.7 | $4.2M | 104k | 40.19 | |
| Syndax Pharmaceuticals (SNDX) | 3.7 | $4.1M | 337k | 12.29 | |
| Ionis Pharmaceuticals (IONS) | 3.6 | $4.1M | 136k | 30.17 | |
| Eli Lilly & Co. (LLY) | 3.4 | $3.9M | 4.7k | 825.91 | |
| Cogent Biosciences (COGT) | 3.3 | $3.7M | 622k | 5.99 | |
| Intuitive Surgical Com New (ISRG) | 2.8 | $3.1M | 6.4k | 495.27 | |
| Soleno Therapeutics | 2.8 | $3.1M | 43k | 71.45 | |
| Akero Therapeutics (AKRO) | 2.7 | $3.1M | 76k | 40.48 | |
| Disc Medicine (IRON) | 2.7 | $3.1M | 62k | 49.64 | |
| Miragen Therapeutics (VRDN) | 2.6 | $2.9M | 217k | 13.48 | |
| Regenxbio Inc equity us cm (RGNX) | 2.6 | $2.9M | 405k | 7.15 | |
| Replimune Group (REPL) | 2.6 | $2.9M | 295k | 9.75 | |
| Scholar Rock Hldg Corp (SRRK) | 2.4 | $2.7M | 84k | 32.15 | |
| Dyne Therapeutics (DYN) | 2.4 | $2.7M | 258k | 10.46 | |
| Natera (NTRA) | 2.3 | $2.6M | 19k | 141.41 | |
| 89bio (ETNB) | 2.3 | $2.6M | 354k | 7.27 | |
| Penumbra (PEN) | 2.1 | $2.4M | 9.0k | 267.41 | |
| Savara (SVRA) | 2.1 | $2.3M | 836k | 2.77 | |
| Anaptysbio Inc Common (ANAB) | 1.9 | $2.2M | 117k | 18.59 | |
| Travere Therapeutics (TVTX) | 1.9 | $2.1M | 118k | 17.92 | |
| Centessa Pharmaceuticals Sponsored Ads | 1.8 | $2.1M | 143k | 14.38 | |
| Ge Healthcare Technologies I Common Stock (GEHC) | 1.8 | $2.1M | 25k | 80.71 | |
| Fulcrum Therapeutics (FULC) | 1.8 | $2.0M | 689k | 2.88 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.6 | $1.8M | 103k | 17.31 | |
| Immunome (IMNM) | 1.6 | $1.8M | 264k | 6.73 | |
| Beigene Sponsored Ads (ONC) | 1.6 | $1.8M | 6.5k | 272.17 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.5 | $1.7M | 51k | 33.54 | |
| Edgewise Therapeutics (EWTX) | 1.4 | $1.6M | 71k | 22.00 | |
| Dr Reddys Labs Adr (RDY) | 1.4 | $1.5M | 118k | 13.19 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.4 | $1.5M | 290k | 5.31 | |
| Karyopharm Therapeutics Com New (KPTI) | 1.4 | $1.5M | 2.0M | 0.76 | |
| Nektar Therapeutics | 1.3 | $1.5M | 2.2M | 0.68 | |
| Arvinas Ord (ARVN) | 1.2 | $1.4M | 195k | 7.02 | |
| Gossamer Bio (GOSS) | 1.1 | $1.2M | 1.1M | 1.10 | |
| Trevi Therapeutics (TRVI) | 0.9 | $1.0M | 164k | 6.29 | |
| Mbx Biosciences (MBX) | 0.9 | $982k | 133k | 7.38 | |
| Biohaven (BHVN) | 0.9 | $959k | 40k | 24.04 | |
| Alvotech Ordinary Shares (ALVO) | 0.8 | $871k | 90k | 9.67 | |
| Vyne Therapeutics (VYNE) | 0.7 | $731k | 463k | 1.58 | |
| Establishment Labs Holdings Ord (ESTA) | 0.5 | $535k | 13k | 40.80 | |
| BioCryst Pharmaceuticals (BCRX) | 0.4 | $455k | 61k | 7.50 | |
| Eledon Pharmaceuticals (ELDN) | 0.3 | $387k | 114k | 3.39 | |
| Akebia Therapeutics (AKBA) | 0.3 | $363k | 189k | 1.92 | |
| Travere Therapeutics Call Call Option | 0.2 | $231k | 110k | 2.10 | |
| Aldeyra Therapeutics Put Put Option | 0.2 | $190k | 100k | 1.90 | |
| Nuvation Bio Com Cl A (NUVB) | 0.2 | $170k | 96k | 1.76 | |
| Cytokinetics Put Put Option | 0.1 | $142k | 23k | 6.15 | |
| Springworks Therapeutics Call Call Option | 0.1 | $129k | 38k | 3.45 | |
| Rhythm Pharmaceuticals Put Put Option | 0.1 | $70k | 40k | 1.75 | |
| Aprea Therapeutics Com New (APRE) | 0.1 | $59k | 29k | 2.04 | |
| Gossamer Bio Call Call Option | 0.0 | $48k | 100k | 0.47 | |
| Nektar Therapeutics Call Call Option | 0.0 | $23k | 75k | 0.30 | |
| Roivant Sciences Put Put Option | 0.0 | $15k | 75k | 0.20 | |
| Veru Call Call Option | 0.0 | $900.000000 | 60k | 0.01 | |
| Soleno Therapeutics Put Put Option | 0.0 | $275.000000 | 11k | 0.03 |
